7 unchanged sentences
Legal Actions
−Removed: Securities Litigation.
On January 16, 2024, a putative class action captioned McAuliffe v.
13 unchanged sentences
On July 11, 2025, the lead plaintiff filed a brief in support of their appeal.
−Removed: On August 15, 2025, Mobileye and the named defendants filed their opposition brief, and on September 5, 2025, the appellants filed their reply brief in further support of the appeal We intend to defend the matter vigorously.
−Removed: No provision was recorded in the condensed consolidated financial statements as of September 27, 2025.
−Removed: Derivative Action - U.S.
−Removed: District Court for the Southern District of New York
−Removed: On April 12, 2024, a derivative lawsuit was filed against the members of the Mobileye Board of Directors and Intel Corporation, in its capacity as Mobileye’s controlling shareholder.
−Removed: Mobileye was also named as a nominal defendant.
−Removed: The complaint principally asserts claims for breach of fiduciary duty and unjust enrichment based on alleged failures to take steps to prevent the Company from making allegedly false and misleading statements concerning the build-up of excess inventory by certain Tier 1 Mobileye customers.
−Removed: The complaint also asserts a claim for violation of Section 14(a) of the Securities Exchange Act of 1934 based on alleged misstatements and omissions in Mobileye’s 2023 proxy statement.
−Removed: The complaint seeks unspecified damages and other relief.
−Removed: Since May 24, 2024, the derivative action has been stayed by the court pending resolution of the anticipated motion to dismiss in the consolidated securities action.
−Removed: On June 27, 2024, an additional derivative lawsuit was filed in the United States District Court for the Southern District of New York against certain members of the Mobileye Board of Directors, certain of Mobileye’s current and former officers, and Intel Corporation, in its capacity as Mobileye’s controlling shareholder.
−Removed: Mobileye was also named as nominal defendant.
−Removed: On July 9th, 2024, this derivative action was consolidated with the derivative action originally filed on April 12, 2024 and the consolidated derivative action was stayed by the court pending resolution of the anticipated motion to dismiss in the consolidated securities action.
−Removed: Following dismissal of the consolidated securities action, the Court ordered the parties to jointly propose a schedule for further proceedings by April 24, 2025.
−Removed: On April 25, 2025, the Court entered a stipulation and order of voluntary dismissal without prejudice.
−Removed: In the event the plaintiffs refile this lawsuit, we intend to continue defending the matter vigorously.
−Removed: No provision was recorded in the condensed consolidated financial statements as of September 27, 2025.
−Removed: Derivative Action - State of Delaware
−Removed: On May 6, 2025, a derivative lawsuit captioned Levitan et al.
−Removed: Shashua et al.
−Removed: was filed in the State of Delaware’s Court of Chancery against certain current and former members of the Mobileye Board of Directors and against Intel Corporation, in its capacity as Mobileye’s controlling shareholder.
−Removed: Mobileye was also named as a nominal defendant.
−Removed: The complaint principally asserts claims for breach of fiduciary duty against the named director defendants and breach of fiduciary duty and unjust enrichment against Intel Corporation, alleging that the named director defendants and Intel should not have authorized Mobileye’s June 5, 2023 secondary offering given their purported knowledge of the alleged challenges facing the Company concerning customer demand and the buildup of excess inventory by Mobileye’s Tier 1 customers.
−Removed: The complaint seeks unspecified damages and other relief.
−Removed: On September 8, 2025, Mobileye, Intel Corporation and the named director defendants filed a motion to dismiss the complaint.
−Removed: We intend to defend the matter vigorously.
−Removed: No provision was recorded in the condensed consolidated financial statements as of September 27, 2025.
+Added: On August 15, 2025, Mobileye and the named defendants filed their opposition brief, and on September 5, 2025, the appellants filed their reply brief in further support of the appeal.
+Added: Oral argument was held on December 4, 2025.
+Added: On December 16, 2025, the Second Circuit issued a summary order affirming the Court’s dismissal of the second amended complaint in full.
+Added: The time for the plaintiff to seek further review by filing a petition for a writ of certiorari with the U.S.
+Added: Supreme Court has expired, and no such petition was filed.
+Added: No provision was recorded in the condensed consolidated financial statements as of March 28, 2026.
Patent Litigation
1 unchanged sentence
(“Facet”) sued Mobileye in the U.S.
−Removed: District Court for the Eastern District of Texas for allegedly infringing two patents.
−Removed: Captioned Facet Technology Corp.
−Removed: Mobileye Global, Inc., the complaint alleges that certain Mobileye products directly and indirectly infringe both patents.
−Removed: The complaint seeks unspecified damages, a permanent injunction, and attorneys’ fees and costs.
−Removed: On November 4, 2024, Mobileye filed a motion to dismiss asserting improper venue, which the court dismissed without prejudice to refile in view of an amended complaint filed by Facet, adding Mobileye Vision Technologies Ltd.
−Removed: and Mobileye Inc., each wholly-owned indirect subsidiaries of Mobileye Global Inc., as additional defendants.
−Removed: On November 7, 2024, Mobileye Vision Technologies Ltd.
−Removed: and Mobileye Inc., sued Facet Technology Corp.
−Removed: District Court of Minnesota seeking a declaratory judgement that the Mobileye plaintiffs do not infringe either patent.
−Removed: On March 5, 2025, the Patent Trial and Appeal Board of the US Patent and Trademark Office instituted two Inter Parte Review (IPR) proceedings filed by Mobileye Vision Technologies Ltd.
−Removed: against the patents asserted by Facet.
−Removed: On March 15, 2025, the parties agreed and the relevant courts entered orders staying all litigation pending the outcome of the IPRs.
−Removed: On March 19, 2025, Facet filed requests for reconsideration of both institution decisions.
−Removed: On April 22, 2025, the Patent Trial and Appeal Board denied Facet’s request for reconsideration in respect of one of the institution decisions.
−Removed: On May 2, 2025, the U.S.
−Removed: Patent and Trademark Office denied Facet’s request for Director Review of the second institution decision.
−Removed: We intend to defend the matter vigorously.
−Removed: No provision was recorded in the condensed consolidated financial statements as of September 27, 2025.
+Added: District Court for the Eastern District of Texas for patent infringement.
+Added: The suit accuses Mobileye Global Inc., Mobileye Vision Technologies Ltd., and Mobileye Inc.
+Added: of allegedly infringing two expired patents.
+Added: Despite expiration of the patents, the suit seeks injunctive relief and a permanent injunction as well as unspecified damages, fees and costs.
+Added: Mobileye Vision Technologies Ltd.
+Added: and Mobileye Inc., sued Facet in the U.S.
+Added: District Court of Minnesota seeking a declaratory judgment of non-infringement of both patents.
+Added: Before either action was answered, the Patent Trial and Appeal Board (“PTAB”) of the US Patent and Trademark Office instituted two Inter Parte Review (IPR) proceedings on both patents, and both district court actions were stayed.
+Added: The parties are challenging aspects of the PTAB’s determinations, and the district court actions remain stayed.
+Added: We intend to defend these matters vigorously.
+Added: No provision was recorded in the condensed consolidated financial statements as of March 28, 2026.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.